Author(s):
Mahima Mahima, Tarique Mahmood, Farogh Ahsan, Akash Ved, Monu Kumar Kashyap
Email(s):
tmahmood@iul.ac.in
DOI:
10.52711/0974-360X.2025.00528 
Address:
Mahima Mahima1*, Tarique Mahmood1*, Farogh Ahsan1, Akash Ved2, Monu Kumar Kashyap3
1Department of Pharmacy, Faculty of Pharmacy, Integral University, Lucknow, India - 226026.
2Dr. A P J Abdul Kalam Technical University, Lucknow, India - 226031.
3Goel Institute of Pharmaceutical Sciences, Lucknow, India - 226010.
*Corresponding Author
Published In:
Volume - 18,
Issue - 8,
Year - 2025
ABSTRACT:
Roxithromycin is a macrocyclic lactone ring containing macrolide antibiotic which targets the protein synthesis of bacterial cells by inhibiting the translocation of 50s ribosomes peptides and its activity is well known. Roxithromycin induces growth arrest and apoptosis in malignant cells by inhibiting the protein synthesis. The aim of this research is to study the impact of roxithromycin and its cytotoxicity on breast cancer cell line (MCF7) by MTT assay and antioxidant activity through DPPH assay and molecular docking is carried out to predict the mechanism of roxithromycin as anticancer agent in breast cancer. In-vitro studies showed the cytotoxic potential of roxithromycin with a IC50 of 95µg/ml and 70µg/ml for roxithromycin and standard respectively. Further in silico studies shows the inhibitory action of roxithromycin with MCL1 and mTORC1 protein with a binding energy of -6.89kcal/mol and -6.67kcal/mol respectively. These parameters have showed a potential cytotoxic and antioxidant activity of roxithromycin in comparison with standard (5-FU) which also has reported free binding energy of of -6.00kcal/mol in previous literatures. This study offers a thorough exploration of roxithromycin potential anticancer properties, elucidating its molecular mechanisms, cytotoxicity, antioxidant activity, and binding interactions with key proteins involved in breast cancer progression. The findings suggest its consideration for in-vivo studies.
Cite this article:
Mahima Mahima, Tarique Mahmood, Farogh Ahsan, Akash Ved, Monu Kumar Kashyap. In-vitro and In-silico Studies to Validate the Repositioning of Roxithromycin in Breast Cancer. Research Journal Pharmacy and Technology. 2025;18(8):3669-3676. doi: 10.52711/0974-360X.2025.00528
Cite(Electronic):
Mahima Mahima, Tarique Mahmood, Farogh Ahsan, Akash Ved, Monu Kumar Kashyap. In-vitro and In-silico Studies to Validate the Repositioning of Roxithromycin in Breast Cancer. Research Journal Pharmacy and Technology. 2025;18(8):3669-3676. doi: 10.52711/0974-360X.2025.00528 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-8-31
REFERENCES:
1. Viswanathan N, Gowri V, Punnagai K; Investigation of In-vitro antiproliferative activity of ampelocissus latifolia root extract on MCF-7 breast cancer cells ampelocissus latifolia root extract against MCF-7 breast cancer cells. Research J. Pharm. and Tech. 2023; 16(8): 3595-3600. doi: 10.52711/0974-360X.2023.00593.
2. Lee, S.H.; Brianna Association of MicroRNA-21 Expression with Breast Cancer Subtypes and Its Potential as an Early Biomarker. Pathol. - Res. Pract. 2024, 155073, doi:10.1016/J.PRP.2023.155073.
3. Weathersby, C.; Mcmichael, A. Brazilian Keratin Hair Treatment: A Review. J. Cosmet. Dermatol. 2013; 12: 144–148. doi:10.1111/JOCD.12030.
4. Hariramani, N. and Jayanthi, S; A systematic review of intrinsic factors and its influence in breast cancer. Research Journal of Pharmacy and Technology. 2018; 11(8): 3543-3546. DOI: 10.5958/0974-360X.2018.00654.6
5. Singh, A.; Ansari, V.A.; Ahsan, F.; Akhtar, J.; Khushwaha, P.; Maheshwari, S.; Rufaida Viridescent Concoction of Genstein Tendentious Silver Nanoparticles for Breast Cancer. Res. J. Pharm. Technol. 2021; 14: 2867–2872. doi:10.52711/0974-360X.2021.00504.
6. Pleasant, V. Management of Breast Complaints and High-Risk Lesions. Best Pract. Res. Clin. Obstet. Gynaecol. 2022; 83: 46–59. doi:10.1016/j.bpobgyn.2022.03.017.
7. Lawson, M.B.; Bissell, M.C.S.; Miglioretti, D.L.; Eavey, J.; Chapman, C.H.; Mandelblatt, J.S.; Onega, T.; Henderson, L.M.; Rauscher, G.H.; Kerlikowske, K.; et al. Multilevel Factors Associated with Time to Biopsy after Abnormal Screening Mammography Results by Race and Ethnicity. JAMA Oncol. 2022; 8: 1115–1126, doi:10.1001/JAMAONCOL.2022.1990.
8. Palmer, J.R.; Zirpoli, G.; Bertrand, K.A.; Battaglia, T.; Bernstein, L.; Ambrosone, C.B.; Bandera, E. V.; Troester, M.A.; Rosenberg, L.; Pfeiffer, R.M.; et al. A Validated Risk Prediction Model for Breast Cancer in US Black Women. J. Clin. Oncol. 2021; 39: 3866–3877. doi:10.1200/JCO.21.01236.
9. Goodman, M.T.; Tung, K.H.; Wilkens, L.R. Comparative Epidemiology of Breast Cancer among Men and Women in the US, 1996 to 2000. Cancer Causes Control. 2006; 17: 127–136. doi:10.1007/S10552-005-5384-Y.
10. Brinton, L.A.; Cook, M.B.; McCormack, V.; Johnson, K.C.; Olsson, H.; Casagrande, J.T.; Cooke, R.; Falk, R.T.; Gapstur, S.M.; Gaudet, M.M.; et al. Anthropometric and Hormonal Risk Factors for Male Breast Cancer: Male Breast Cancer Pooling Project Results. J. Natl. Cancer Inst. 2014, 106, doi:10.1093/JNCI/DJT465.
11. Bodewes, F.T.H.; van Asselt, A.A.; Dorrius, M.D.; Greuter, M.J.W.; de Bock, G.H. Mammographic Breast Density and the Risk of Breast Cancer: A Systematic Review and Meta-Analysis. Breast. 2022; 66: 62–68, doi:10.1016/j.breast.2022.09.007.
12. DeSantis, C.E.; Miller, K.D.; Goding Sauer, A.; Jemal, A.; Siegel, R.L. Cancer Statistics for African Americans, 2019. CA. Cancer J. Clin. 2019; 69: 211–233. doi:10.3322/CAAC.21555.
13. Singh, N.; Kushwaha, P.; Gupta, A.; Prakash, O. Recent Advances of Novel Therapeutic Agents from Botanicals for Prevention and Therapy of Breast Cancer: An Updated Review. Curr. Cancer Ther. Rev. 2018; 16, 5–18, doi:10.2174/1573394715666181129101502.
14. Piyush, K.; Kuldeep, S.; Azizur, R.M.; Misbahul, H.S.; Pranay, W. A Review of Benzopyran Derivatives in Pharmacotherapy of Breast Cancer. Asian J. Pharm. Clin. Res. 2018; 11: 43–46, doi:10.22159/ajpcr.2018.v11i7.26017.
15. Al-Owaidi, M.F. and Al Ameri, M.F. Docking study, ADMET profiling of the designed 3-chlorobenzo [b] thiophene-2-carbonyl chloride derivatives: Promising anti-breast cancer activity. Research Journal of Pharmacy and Technology. 2023; 16(2): 901-907. DOI: 10.52711/0974-360X.2023.00152.
16. Wilkerson, A.D.; Obi, M.; Ortega, C.; Sebikali-Potts, A.; Wei, W.; Pederson, H.J.; Al-Hilli, Z. Young Black Women May Be More Likely to Have First Mammogram Cancers: A New Perspective in Breast Cancer Disparities. Ann. Surg. Oncol. 2023; 30: 2856–2869. doi:10.1245/S10434-022-12995-Y.
17. Jainab, N.H. and Raja, M.K. In silico molecular docking studies on the chemical constituents of clerodendrum phlomidis for its cytotoxic potential against breast cancer markers. Research Journal of Pharmacy and Technology. 2018; 11(4): 1612-1618. DOI: 10.5958/0974-360X.2018.00300.1
18. Wiyono, L., Edina, B.C., Rahmawanti, R.A., Azizah, N.N., Paramita, R.I., Purwaningsih, E.H. and Fadilah, F. Isolation, synthesis nanoparticle, and in-vitro test of pinostrobin from Kaempferia pandurata on MCF-7 and MDAMB-231 breast cancer cell. Research Journal of Pharmacy and Technology. 2020; 13(6): 2797-2801. DOI: 10.5958/0974-360X.2020.00497.7
19. Sogunro, O.A.; Maini, M.; Deldar, R.; Maini, A.S.; Greige, N.; Greenwalt, I.; Wehner, P.; De La Cruz, L.; Son, J.D. Prognostic Predictors of Mortality in Male Breast Cancer: Outcomes in an Urban Population. J. Surg. Res. 2023; 281: 192–199. doi:10.1016/j.jss.2022.08.035.
20. Hemalatha, C.N., Anbarasu, K. and Aanandhi, V.M. Evaluation of anti-cancer and anti-oxidant activity of Cissus quandrangularis extracts in DMBA induced mammary carcinomas. Research Journal of Pharmacy and Technology. 2017; 10(1): 293-300. DOI: 10.5958/0974-360X.2017.00060.9
21. Rauscher, G.H.; Allgood, K.L.; Whitman, S.; Conant, E. Disparities in Screening Mammography Services by Race/Ethnicity and Health Insurance. J. Women’s Heal. 2012; 21: 154–160. doi:10.1089/JWH.2010.2415.
22. Stiel, L.; Adkins-Jackson, P.B.; Clark, P.; Mitchell, E.; Montgomery, S. A Review of Hair Product Use on Breast Cancer Risk in African American Women. Cancer Med. 2016, 5, 597–604, doi:10.1002/CAM4.613.
23. Abdulqawi, L.N.A., Quadri, S.A., Islam, S. and Santra, M.K. Evaluation of anticancer activity of Withania somnifera L. and Tribulus terrestris L. on human breast cancer cells In vitro. Research Journal of Pharmacy and Technology. 2023; 16(7): 3079-3082. DOI: 10.52711/0974-360X.2023.00506.
24. Fentiman, I.S.; Fourquet, A.; Hortobagyi, G.N. Male Breast Cancer. Lancet. 2006; 367: 595–604. doi:10.1016/S0140-6736(06)68226-3.
25. Scientist, S. Role of Bisphenol A Indiuced Lipogenesis in Breast Cancer Cells Submitted to The Faculty of Engineering Integral University , Lucknow In Partial Fulfilment Dr . Pradeep Kumar Sharma Integral University, Dasauli, Kursi Road.
26. Ansari, J.A.; Rastogi, N.; Ahmad, M.K.; Mahdi, A.A.; Khan, A.R.; Thakur, R.; Srivastava, V.K.; Mishra, D.P.; Fatima, N.; Khan, H.J.; et al. ROS Mediated Pro-Apoptotic Effects of Tinospora Cordifolia on Breast Cancer Cells. Front. Biosci. - Elit. 2017, 9, 89–101. doi:10.2741/e788.
27. Giordano, S.H. A Review of the Diagnosis and Management of Male Breast Cancer. Oncologist. 2005, 10, 471–479, doi:10.1634/THEONCOLOGIST.10-7-471.
28. Bea, V.J.; Jerome-D’Emilia, B.; Antoine, F.; Wiggins, P.; Hyman, D.; Robles-Rodriguez, E. Sister, Give Me Your Hand: A Qualitative Focus Group Study on Beliefs and Barriers to Mammography Screening in Black Women During the COVID-19 Era. J. Racial Ethn. Heal. Disparities. 2023, 10, 1466–1477, doi:10.1007/S40615-022-01332-4.
29. Morrow, M.; Schnitt, S.J.; Norton, L. Current Management of Lesions Associated with an Increased Risk of Breast Cancer. Nat. Rev. Clin. Oncol. 2015, 12, 227–238, doi:10.1038/NRCLINONC.2015.8.
30. Sasikala, M., Sundaraganapathy, R. and Mohan, S. MTT Assay on Anticancer Properties of Phytoconstituents from Ipomoea aquatica forsskal using MCF-7 cell lines for breast cancer in Women. Research Journal of Pharmacy and Technology. 2020; 13(3): 1356-1360. DOI: 10.5958/0974-360X.2020.00250.4
31. Ahirwar, B. and Ahirwar, D. In vivo and in vitro investigation of cytotoxic and antitumor activities of polyphenolic leaf extract of Hibiscus sabdariffa against breast cancer cell lines. Research Journal of Pharmacy and Technology. 2020; 13(2): 615-620. DOI: 10.5958/0974-360X.2020.00116.X
32. Jones, B.A.; Kasl, S. V.; McCrea Curnen, M.G.; Owens, P.H.; Dubrow, R. Severe Obesity as an Explanatory Factor for the Black/White Difference in Stage at Diagnosis of Breast Cancer. Am. J. Epidemiol. 1997: 146: 394–404. doi:10.1093/OXFORDJOURNALS.AJE.A009292.
33. Ambinder, E.B.; Oluyemi, E.; Kong, X.; Nguyen, D.L.; Visvanathan, K. Disparities in the Uptake of Digital Breast Tomosynthesis for Breast Cancer Screening: A Retrospective Cohort Study. Breast J. 2021; 27: 872–876. doi:10.1111/TBJ.14292.
34. Sutton, A.L.; Felix, A.S.; Wahl, S.; Franco, R.L.; Leicht, Z.; Williams, K.P.; Hundley, W.G.; Sheppard, V.B. Racial Disparities in Treatment-Related Cardiovascular Toxicities amongst Women with Breast Cancer: A Scoping Review. J. Cancer Surviv. 2023, 17, 1596–1605, doi:10.1007/S11764-022-01210-2.
35. Mallozzi, M.; Leone, C.; Manurita, F.; Bellati, F.; Caserta, D. Endocrine Disrupting Chemicals and Endometrial Cancer: An Overview of Recent Laboratory Evidence and Epidemiological Studies. Int. J. Environ. Res. Public Health. 2017, 14, doi:10.3390/IJERPH14030334.
36. Jones, T.; Wisdom-Chambers, K.; Freeman, K.; Edwards, K. Barriers to Mammography Screening among Black Women at a Community Health Center in South Florida, USA. Med. Res. Arch. 2023, 11, doi:10.18103/MRA.V11I4.3814.
37. Akshata Desai, K.A. Triple Negative Breast Cancer – An Overview. Hered. Genet.2012. doi:10.4172/2161-1041.S2-001.
38. Deluche, E.; Coudert, P.E.; Darbas, T.; Pinet, S.; Labriffe, M.; Laloze, J.; Taibi, A.; Roux, A.; Usseglio-Grosso, J.; Messager, V.; et al. ACACIAS 3: Learning about Announcement Consultations in the Second Cycle of Medical Studies. Bull. Cancer2023, doi:10.1016/j.bulcan.2023.10.004.
39. Costa, L.; Kumar, R.; Villarreal-Garza, C.; Sinha, S.; Saini, S.; Semwal, J.; Saxsena, V.; Zamre, V.; Ray, M.; Shimizu, C.; et al. Diagnostic Delays in Breast Cancer among Young Women: An Emphasis on Healthcare Providers. The Breast. 2023, 103623, doi:10.1016/J.BREAST.2023.103623.
40. McDonald, J.A.; Goyal, A.; Terry, M.B. Alcohol Intake and Breast Cancer Risk: Weighing the Overall Evidence. Curr. Breast Cancer Rep.2013, 5, 208–221, doi:10.1007/S12609-013-0114-Z.
41. Sperduto, W.; McCullough, A.; Northfelt, D.; McGee, L.; Pockaj, B.; Jogerst, K. Implications of a Supernumerary Nipple Breast Cancer in a BReast CAncer Sequence Variation Carrier: A Case Report. Mayo Clin. Proc. Innov. Qual. Outcomes. 2023; 7: 437–442. doi:10.1016/j.mayocpiqo.2023.08.006.
42. Maciej Serda; Becker, F.G.; Cleary, M.; Team, R.M.; Holtermann, H.; The, D.; Agenda, N.; Science, P.; Sk, S.K.; Hinnebusch, R.; et al. Synteza i Aktywność Biologiczna Nowych Analogów Tiosemikarbazonowych Chelatorów Żelaza. Uniw. Sląski. 2013; 7: 343–354. doi:10.2/JQUERY.MIN.JS.
43. Dwivedi, P.S.R.; Shastry, C.S. Anti-Tumor Potential and Mode of Action of Karanjin against Breast Cancer; an in-Silico Approach. Arab. J. Chem. 2023; 16: 104778. doi:10.1016/j.arabjc.2023.104778.
44. Alwattar M, Shalan N, Alaraj M. Anticancer effects of date seed oil-loaded niosomes and gemcitabine combination in MCF-7 human breast cancer cells. Research Journal of Pharmacy and Technology. 2023; 16(9): 4179-87. DOI: 10.52711/0974-360X.2023.00684.
45. Dayana Jeyaleela, G.; Rosaline Vimala, J. Separation, Identification and Anti-Breast Cancer Efficacy of Anthocyanin of Melia Dubia Bark. Mater. Lett. X2024, 21, 100223, doi:10.1016/J.MLBLUX.2023.100223.
46. Li, Y.; Ling Ma, N.; Chen, H.; Zhong, J.; Zhang, D.; Peng, W.; Shiung Lam, S.; Yang, Y.; Yue, X.; Yan, L.; et al. High-Throughput Screening of Ancient Forest Plant Extracts Shows Cytotoxicity towards Triple-Negative Breast Cancer. Environ. Int. 2023, 181, 108279. doi:10.1016/J.ENVINT.2023.108279.